Go to deals
Saúde

Building a leading one-stop ambulatory cancer center

Fevereiro 2024 — SIAMH has successfully registered the offer document, launched an IPO and raised US$19.5 million.

SIAMH is a one-stop outpatient diagnostics and treatment center for cancer, neurogenerative and cardiovascular diseases in Singapore.

O nosso papel na transação

Oaklins’ team in Singapore acted as sponsor, issue manager, underwriter and placement agent in this transaction.

Falar com a equipa da transação

Mark Liew

Partner
Singapura, Singapura
Oaklins PrimePartners

Transações relacionadas

UKAT Group has acquired Bayberry Limited
Private Equity | Saúde

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Saber mais
Medicija has acquired Saulės Šeimos Medicinos Centras
Saúde

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Saber mais
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Saúde

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Saber mais